Specimen Banking From Patients With Lung Cancer

Lung Neoplasms Clinical Trial

Official title:

Specimen Banking From Patients With Lung Cancer

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01585675
• Other study ID #: 04-0688.cc
• Secondary ID: P50CA058187
• Status: Recruiting
• Start date: November 3, 2005
• Est. completion date: July 1, 2035

Study information

• Verified date: December 2023
• Source: University of Colorado, Denver
• Contact: Brandi Kubala
• Phone: 303-724-1657
• Email: brandi.kubala[@]cuanschutz.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

Description:

The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: July 1, 2035
• Est. primary completion date: July 1, 2035
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.

2. Oral and written informed consent

Exclusion Criteria:

1. Any individual who does not give oral and written consent for participation

Related Conditions & MeSH terms

• Lung Neoplasms

Locations

Country	Name	City	State
United States	University of Colorado Cancer Center	Aurora	Colorado

Sponsors (2)

Lead Sponsor	Collaborator
University of Colorado, Denver	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Development of a comprehensive specimen banking program from patients with lung cancer for future translational research.	No statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.	6 years